Boston Scientific is diving into the field of intravascular lithotripsy ... to buy Cardiovascular Systems and its Diamondback 360 mechanical orbital atherectomy portfolio.

The Bolt Medical deal could be even bigger, with Boston Scientific buying the 74% of this intravascular lithotripsy (using sound waves to break up calcified lesions) company it didn’t already ...

Boston Scientific Corporation today announced it has entered into a definitive agreement to acquire Bolt Medical, Inc., the developer of an intravascular lithotripsy (IVL) advanced laser-based ...

Plans to buy Bolt Medical, Inc., a developer of intravascular lithotripsy equipment for treating hardened coronary and peripheral artery disease, were announced by Boston Scientific Corporation ...

to improve blood flow in a procedure known as intravascular lithotripsy. The acquisition will cost Boston Scientific approximately $443 million for the 74% of the remaining stake and up to $221 ...

Prior to the ownership hike, Boston Scientific already owned more than 20 percent of Bolt Medical. Its acquisition will allow the company to enter the intravascular lithotripsy (IVL) market.

Boston Scientific Corp. is paying $443 million ... In November, Bolt announced it had completed two trials of its intravascular lithotripsy (IVL) laser-based catheter that would be used to seek ...

The acquisition is part of Boston Scientific's strategy to enhance its cardiovascular product offerings with the addition of Bolt Medical's intravascular lithotripsy (IVL) technology. The IVL ...

Lithotripsy is a procedure in which a physician ... energy delivery in the treatment of the calcified lesions. Boston Scientific initially developed the concept for the Bolt IVL system which ...